Added to YB: 2024-08-15
Pitch date: 2024-08-14
FNCH [bullish]
Finch Therapeutics Group, Inc.
+20.55%
current return
Author Info
Multibagger Monitor focuses on event-driven, reflexive, and microcap situations with the potential to appreciate rapidly in <2 years. Sign up for the newsletter.
Company Info
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
Market Cap
$24.7M
Pitch Price
$11.00
Price Target
22.00 (+66%)
Dividend
N/A
Sector
Biotechnology
Category
special_situation
Finch Therapeutics' Post-Trial Scenario and the Long Investment Potential
FNCH: Likely wind-down post-trial. Conservative est. $47m return to shareholders after legal fees/award. Potential for enhanced damages (up to 3x) based on willful infringement finding. Judge's harsh comments on Ferring's behavior suggest higher damages possible. Shumway Capital (board members) likely to push for return of capital. Long position.
Read full article (1 min)